NCT00709215 - Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Refractory TdT-Positive Leukemia

Interventions

DRUG

Cordycepin plus Pentostatin

Cordycepin Plus Pentostatin on days 1, 2 and 3 of a 21 day cycle. Number of cycles until progression or unacceptable toxicity

Trial Locations (3)

RECRUITING

Cancer Therapy Reasearch Center at UTHSCA, San Antonio

RECRUITING

Brigham & Women's Hospital, Boston

RECRUITING

Dana Farber Cancer Institute, Boston